Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Bladder Cancer

  Free Subscription


03.08.2020

1 Aktuelle Urol
1 Ann Epidemiol
1 Anticancer Res
2 Arch Pathol Lab Med
1 Biomaterials
1 BMC Health Serv Res
1 Br J Radiol
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
1 Eur Rev Med Pharmacol Sci
1 FASEB J
1 Int J Cancer
1 Int J Mol Med
1 Int J Oncol
1 Integr Cancer Ther
1 Ir J Med Sci
1 J Clin Med
3 J Urol
1 Life Sci
1 Med Hypotheses
3 Medicine (Baltimore)
1 Nutrients
2 Oncol Lett
1 Pathol Res Pract
1 Rev Esp Patol
2 Urol Oncol
3 Urology
1 Virchows Arch
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aktuelle Urol

  1. KRAMER MW, Bolenz C
    [Rapid Progress in the treatment of bladder cancer: recent achievements].
    Aktuelle Urol. 2020;51:342-343.
    PubMed        


    Ann Epidemiol

  2. AKUSHEVICH I, Yashkin AP, Inman BA, Sloan F, et al
    Partitioning of time trends in prevalence and mortality of bladder cancer in the United States.
    Ann Epidemiol. 2020;47:25-29.
    PubMed         Abstract available


    Anticancer Res

  3. HAGA N, Tsubouchi K, Maruta H, Koguchi T, et al
    Increase in Circulating Tumor Cells in Invasive Bladder Cancer After Transurethral Resection of Bladder Tumor.
    Anticancer Res. 2020;40:4299-4307.
    PubMed         Abstract available


    Arch Pathol Lab Med

  4. CORNEJO KM, Rice-Stitt T, Wu CL
    Updates in Staging and Reporting of Genitourinary Malignancies.
    Arch Pathol Lab Med. 2020;144:305-319.
    PubMed         Abstract available

  5. RICE-STITT T, Valencia-Guerrero A, Cornejo KM, Wu CL, et al
    Updates in Histologic Grading of Urologic Neoplasms.
    Arch Pathol Lab Med. 2020;144:335-343.
    PubMed         Abstract available


    Biomaterials

  6. QIU Y, Qiu S, Deng L, Nie L, et al
    Biomaterial 3D collagen I gel culture model: A novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment.
    Biomaterials. 2020;256:120217.
    PubMed         Abstract available


    BMC Health Serv Res

  7. LEE CT, Mohamed NE, Pisipati S, Shah QN, et al
    Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
    BMC Health Serv Res. 2020;20:686.
    PubMed         Abstract available


    Br J Radiol

  8. ROGERS J, Sherwood V, Wayte SC, Duffy JA, et al
    Quantification and correction of distortion in diffusion-weighted-MRI at 1.5 and 3 T in a muscle-invasive bladder cancer phantom for radiotherapy planning.
    Br J Radiol. 2020 Jul 24:20190710. doi: 10.1259/bjr.20190710.
    PubMed         Abstract available


    Clin Genitourin Cancer

  9. SPEIR RW, Barboza MP, Calaway A, Masterson TA, et al
    Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?
    Clin Genitourin Cancer. 2020 Jun 19. pii: S1558-7673(20)30143.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  10. FRANZESE C, Francolini G, Nicosia L, Alongi F, et al
    Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies.
    Clin Oncol (R Coll Radiol). 2020 Jul 25. pii: S0936-6555(20)30290.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  11. YU X, Wang ZL, Han CL, Wang MW, et al
    LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:7203.
    PubMed         Abstract available


    FASEB J

  12. LI Q, Huyan T, Cai S, Huang Q, et al
    The role of exosomal miR-375-3p: A potential suppressor in bladder cancer via the Wnt/beta-catenin pathway.
    FASEB J. 2020 Jul 27. doi: 10.1096/fj.202000347.
    PubMed         Abstract available


    Int J Cancer

  13. ZHOU Q, Zhang H, Wang Z, Zeng H, et al
    Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
    Int J Cancer. 2020 Jul 31. doi: 10.1002/ijc.33237.
    PubMed         Abstract available


    Int J Mol Med

  14. WANG F, Liu P, An H, Zhang Y, et al
    Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT1.
    Int J Mol Med. 2020;46:1085-1095.
    PubMed         Abstract available


    Int J Oncol

  15. LIU Z, Yang Y, Yang Z, Xia S, et al
    Novel circRNA_0071196/miRNA19b3p/CIT axis is associated with proliferation and migration of bladder cancer.
    Int J Oncol. 2020;57:767-779.
    PubMed         Abstract available


    Integr Cancer Ther

  16. SUN M, Bu R, Zhang B, Cao Y, et al
    Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.
    Integr Cancer Ther. 2020;19:1534735420946823.
    PubMed         Abstract available


    Ir J Med Sci

  17. O'MEARA S, Bhatt NR, Flynn RJ, Manecksha RP, et al
    Bladder cancer in Ireland: a 21-year review.
    Ir J Med Sci. 2020 Jul 29. pii: 10.1007/s11845-020-02318.
    PubMed         Abstract available


    J Clin Med

  18. MOSCHINI M
    From Basic Science to Clinical Research to Develop New Solutions to Improve Diagnoses and Treatment of Bladder Cancer Patients.
    J Clin Med. 2020;9.
    PubMed         Abstract available


    J Urol

  19. OSTERMAN CK, Deal AM, McCloskey H, Nyrop KA, et al
    Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Jul 27:101097JU0000000000001323. doi: 10.1097/JU.0000000000001323.
    PubMed         Abstract available

  20. CHANG SS
    Re: STAG2 is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2020 Jul 27:101097JU000000000000121902.
    PubMed        

  21. ATALA A
    Re: The CUL4B-miR-372/373-PIK3CA-AKT Axis Regulates Metastasis in Bladder Cancer.
    J Urol. 2020 Jul 27:101097JU000000000000122201.
    PubMed        


    Life Sci

  22. LU N, Piao MH, Feng CS, Yuan Y, et al
    Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1alpha-beta-catenin/Notch1 pathways.
    Life Sci. 2020 Jul 28:118154. doi: 10.1016/j.lfs.2020.118154.
    PubMed         Abstract available


    Med Hypotheses

  23. TIAN J, Fu G, Xu Z, Chen X, et al
    Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy.
    Med Hypotheses. 2020;143:110100.
    PubMed         Abstract available


    Medicine (Baltimore)

  24. VLAD O, Catalin B, Mihai H, Adrian P, et al
    Enhanced recovery after surgery (ERAS) protocols in patients undergoing radical cystectomy with ileal urinary diversions: A randomized controlled trial.
    Medicine (Baltimore). 2020;99:e20902.
    PubMed         Abstract available

  25. XU H, Chen Z, Shen B, Wei Z, et al
    Primary bladder mucosa-associated lymphoid tissue lymphoma: A case report and literature review.
    Medicine (Baltimore). 2020;99:e20825.
    PubMed         Abstract available

  26. TAO TT, Chen J, Hu Q, Huang XJ, et al
    Urothelial carcinoma of the bladder with abundant myxoid stroma: A case report and literature review.
    Medicine (Baltimore). 2020;99:e21204.
    PubMed         Abstract available


    Nutrients

  27. SONG JH, Won SY, Hwang B, Jung S, et al
    In Vitro and In Vivo Antitumor Efficacy of Hizikia fusiforme Celluclast Extract against Bladder Cancer.
    Nutrients. 2020;12.
    PubMed         Abstract available


    Oncol Lett

  28. WANG Y, Ba HJ, Liu ZC, Deng XB, et al
    Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study.
    Oncol Lett. 2020;20:1677-1684.
    PubMed         Abstract available

  29. LEI S, Xu H, Chen N, Pan H, et al
    MKP-1 overexpression is associated with chemoresistance in bladder cancer via the MAPK pathway.
    Oncol Lett. 2020;20:1743-1751.
    PubMed         Abstract available


    Pathol Res Pract

  30. FRANCESCHINI T, Capizzi E, Massari F, Schiavina R, et al
    Immunohistochemical over-expression of HER2 does not always match with gene amplification in invasive bladder cancer.
    Pathol Res Pract. 2020;216:153012.
    PubMed         Abstract available


    Rev Esp Patol

  31. NAVARRO CONDE P, Alemany Monraval P, Medina Medina C, Jimenez Sanchez A, et al
    Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
    Rev Esp Patol. 2020;53:188-192.
    PubMed         Abstract available


    Urol Oncol

  32. FUJITA N, Hatakeyama S, Okita K, Momota M, et al
    Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guerin therapy.
    Urol Oncol. 2020 Jul 23. pii: S1078-1439(20)30319.
    PubMed         Abstract available

  33. JUVET T, Mari A, Lajkosz K, Wallis CJ, et al
    Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.
    Urol Oncol. 2020 Jul 22. pii: S1078-1439(20)30318.
    PubMed         Abstract available


    Urology

  34. CORNELISSEN SWE, Veenboer PW, Wessels FJ, Meijer RP, et al
    Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: A systematic review and meta-analysis.
    Urology. 2020 Jul 25. pii: S0090-4295(20)30882.
    PubMed         Abstract available

  35. RICHARDS KA, Lin SW, Chuo CY, Derleth CL, et al
    Increased Bacillus Calmette-Guerin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non-Muscle-Invasive Bladder Cancer in US Clinical Practice.
    Urology. 2020 Jul 24. pii: S0090-4295(20)30884.
    PubMed         Abstract available

  36. BUKAVINA L, Prunty M, Mishra K, Sun H, et al
    Gender Disparities in Bladder Cancer Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS).
    Urology. 2020 Jul 21. pii: S0090-4295(20)30868.
    PubMed         Abstract available


    Virchows Arch

  37. PIERCONTI F, Raspollini MR, Martini M, Larocca LM, et al
    PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders.
    Virchows Arch. 2020;477:269-277.
    PubMed         Abstract available


    World J Urol

  38. ZAMBONI S, Afferi L, Soria F, Aziz A, et al
    Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent.
    World J Urol. 2020 Jul 25. pii: 10.1007/s00345-020-03362.
    PubMed         Abstract available

  39. FULETRA JG, Watts A, Kaag MG, Lehman E, et al
    Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?
    World J Urol. 2020 Jul 28. pii: 10.1007/s00345-020-03375.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: